Targeting the alloimmune response for prevention of chronic graft loss: efficacy of new immunosuppressive drugs.
Eisen
H J
HJ
Cardiac Transplant Program, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
D000917:Antibody Formation; D002908:Chronic Disease; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control*; D006680:HLA Antigens / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007519:Isoantigens / Q000096:biosynthesis; D013601:T-Lymphocytes / Q000276:immunology
D006680:HLA Antigens; D007166:Immunosuppressive Agents; D007519:Isoantigens